Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

  • R. Chilton, I. Tikkanen, C. P. Cannon, S. Crowe, H. J. Woerle, U. C. Broedl, O. E. Johansen
  • Diabetes Obesity and Metabolism, October 2015, Wiley
  • DOI: 10.1111/dom.12572

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/dom.12572

In partnership with:

Link to Wiley showcase